BBIO

Bridgebio Pharma Inc
Health CareUSCUSIP 10806X102◍ Confluence graph
Tracked 13F Holders
417
-170 QoQ
13F Value (tracked)
$11.7B
Insider Net · 180d
-$54.0M
0↑ 7↓
Recent Filings
15
Smart-money sentimentMixed
BearishBullish
13F funds (latest Q)41 adding · 22 trimming
Insider net (180d)-$54.0M

Who owns BBIO?

417 tracked 13F filers

417 tracked 13F filers disclose a position in BBIO as of the latest SEC 13F filings, a combined $11.7B in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.

All quarters use one ordinary-share-equivalent series. Historical ADS are converted at 2 ADS = 1 ordinary share. Expand a row for the exact calculation; the residual is not classified as a trade.
#FundPosition valueSharesLast moveAs ofHistory
1BlackRock, Inc.
$1.1B
14.2M
−2.3%
Reduced · −342K sh
Q1 2026
2JANUS HENDERSON GROUP PLC
$978.6M
13.2M
+20%
Added · +2.2M sh
Q1 2026
3VIKING GLOBAL INVESTORS LP
$879.4M
11.8M
−18%
Reduced · −2.6M sh
Q1 2026
4FARALLON CAPITAL MANAGEMENT LLC
$695.5M
9.4M
+4.1%
Added · +367K sh
Q1 2026
5VANGUARD PORTFOLIO MANAGEMENT LLC
$600.1M
8.1M
First observed position
No prior filed position
Q1 2026
6VANGUARD CAPITAL MANAGEMENT LLC
$576.2M
7.8M
First observed position
No prior filed position
Q1 2026
7STATE STREET CORP
$330.4M
4.4M
−10%
Reduced · −498K sh
Q2 2026
8PRICE T ROWE ASSOCIATES INC /MD/
$282.3M
3.8M
−0.7%
Reduced · −27K sh
Q1 2026
9GEODE CAPITAL MANAGEMENT, LLC
$254.7M
3.4M
−30%
Reduced · −1.5M sh
Q2 2026
10CITADEL ADVISORS LLC
$235.7M
3.2M
+355%
Added · +2.5M sh
Q1 2026
11TWO SIGMA INVESTMENTS, LP
$231.7M
3.1M
+60%
Added · +1.2M sh
Q1 2026
12D. E. Shaw & Co., Inc.
$189.0M
2.5M
+15%
Added · +331K sh
Q1 2026
13FRANKLIN RESOURCES INC
$181.1M
2.4M
+13%
Added · +274K sh
Q1 2026
14FMR LLC
$174.0M
2.3M
−1.9%
Reduced · −47K sh
Q1 2026
15Polar Capital Holdings Plc
$153.7M
2.1M
−18%
Reduced · −456K sh
Q2 2026
16UBS Group AG
$150.5M
2.0M
+8.1%
Added · +151K sh
Q1 2026
17MANUFACTURERS LIFE INSURANCE COMPANY, THE
$146.8M
2.0M
+0.1%
Added · +2K sh
Q1 2026
18CHARLES SCHWAB INVESTMENT MANAGEMENT INC
$146.7M
2.0M
+0.6%
Added · +12K sh
Q1 2026
19ALLIANCEBERNSTEIN L.P.
$146.0M
1.9M
−6.9%
Reduced · −142K sh
Q1 2026
20GOLDMAN SACHS GROUP INC
$140.9M
1.9M
+6.4%
Added · +115K sh
Q1 2026
21MORGAN STANLEY
$139.4M
1.9M
+34%
Added · +478K sh
Q1 2026
22SC US (TTGP), LTD.
$138.2M
1.9M
Held
Q1 2026
23JANE STREET GROUP, LLC
$130.5M
1.8M
+414%
Added · +1.4M sh
Q1 2026
24Frazier Life Sciences Management, L.P.
$115.3M
1.5M
−55%
Reduced · −1.9M sh
Q2 2026
25NORGES BANK
$116.8M
1.5M
−22%
Reduced · −430K sh
Q4 2025

Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.

Is BBIO being bought or sold by institutions?

Last quarter, 2 funds opened a new position in BBIO and 39 added to an existing one, while 22 reduced and 0 exited entirely — based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).

Opened (NEW)
2
funds
Added
39
funds
Reduced
22
funds
Exited
0
funds

Funds that own BBIO also own

CompanyCo-held byCombined value
ELI LILLY & COLLY236 funds$87.6B
AMAZON.COM INCAMZN233 funds$204.2B
NVIDIA CORPNVDA232 funds$404.8B
MICROSOFT CORPMSFT232 funds$275.8B
META PLATFORMS INC-CLASS AMETA229 funds$117.2B
BROADCOM INCAVGO227 funds$156.3B
APPLE INCAAPL222 funds$302.8B
ALPHABET INC-CL AGOOGL220 funds$181.7B
VISA INC-CLASS A SHARESV219 funds$65.4B
MICRON TECHNOLOGY INCMU219 funds$49.6B
LAM RESEARCH CORPLRCX219 funds$36.4B
JPMORGAN CHASE & COJPM218 funds$70.4B

Ranked by how many of BBIO's institutional holders also hold each name, a cross-fund conviction signal.

Insider activity (Form 4)

Full insider page →
Buys · 180d
$0
0 insiders
Sells · 180d
$54.0M
7 insiders
Net
-$54.0M
74 P/S txns
Signal
Net Selling
open-market
DateInsiderRoleActionSharesValue
Aug 19, 2026Kumar NeilChief Executive Officer, DirectorSell (S)100$9K
Aug 19, 2026Kumar NeilChief Executive Officer, DirectorSell (S)2K$152K
Aug 19, 2026Kumar NeilChief Executive Officer, DirectorSell (S)8K$679K
Aug 18, 2026Kumar NeilChief Executive Officer, DirectorSell (S)1K$100K
Aug 18, 2026Kumar NeilChief Executive Officer, DirectorSell (S)15K$1.2M
Aug 18, 2026Kumar NeilChief Executive Officer, DirectorSell (S)17K$1.4M
Aug 18, 2026Kumar NeilChief Executive Officer, DirectorSell (S)2K$154K
Jul 30, 2026Apuli MaricelChief Accounting OfficerSell (S)2K$160K
Jul 9, 2026Ellis AndreaDirectorSell (S)17K$1.4M
Jul 9, 2026Cook Jennifer E.DirectorSell (S)36K$3.0M
Jul 9, 2026Cook Jennifer E.DirectorSell (S)112K$10.1M
Jun 24, 2026Cook Jennifer E.DirectorSell (S)37K$2.6M

Institutional ownership over time

222 funds+40 since Q3 2024
0196392Q3 2024Q1 2025Q3 2025Q1 2026Q2 2026
funds holding aggregate valuelatest $1.9B

Share classes

Class13F holdersValue held
BBIOthis pagecs417 funds$11.7B
BBIO 1.75 03/01/31SDBCV39 funds$912.9M
BBIO 2.5 03/15/27Sovereign/Corporate37 funds$690.6M
BBIO 2.25 02/01/29SDBCV34 funds$735.6M

Same issuer, multiple share classes. The consensus leaderboards count this company once across all classes; this is the per-class detail.

Recent filings

15 shown

Keep exploring

Connected entities for BBIO

Browse more

Build

Ask your agent what changed in BBIO

This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/stocks/BBIO/capital-change-brief"
Ask your agent
Use Arkolith's capital_change_brief for BBIO.
Tell me what changed, whether insider activity
corroborates it, and cite the SEC evidence.

13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for BBIO. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.